CVE(CVE)
CVE
Q3 2026 EPS Estimate
$1.12
Jul 30, 2026 · Reports before open
Revenue Estimate
$11.84B
FY2026E EPS$4.45
FY2027E EPS$3.55
Analyst Sentiment
Wall St. Consensus
Hold26 analysts·High coverage
60
Score
11 Buy (42%)14 Hold (54%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
1142%
Hold
1454%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$22.00
-15.3%
Consensus
$29.00
+11.6%
Bull
$36.00
+38.6%
12-Month Target Range26 analysts
$22.00$29.00$36.00
Current $25.98Consensus
Current Price
$25.98
Upside to Consensus
$3.02
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-6.99%
EPS-20.29%
FY2028
Rev+6.76%
EPS+10.15%
FY2029
Rev-11.85%
EPS+13.95%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $56.05B | $52.13B | $55.66B | $49.06B | $49.29B |
| Low | $50.22B | $44.80B | $48.06B | $42.36B | $42.56B |
| High | $61.25B | $60.66B | $61.99B | $54.64B | $54.90B |
| EBITDA Avg | $10.06B | $9.36B | $9.99B | $8.81B | $8.85B |
| Low | $9.02B | $8.04B | $8.63B | $7.61B | $7.64B |
| High | $11.00B | $10.89B | $11.13B | $9.81B | $9.86B |
| EBIT Avg | $5.23B | $4.86B | $5.19B | $4.58B | $4.60B |
| Low | $4.69B | $4.18B | $4.48B | $3.95B | $3.97B |
| High | $5.72B | $5.66B | $5.78B | $5.10B | $5.12B |
| Net Income Avg | $8.06B | $6.32B | $8.23B | $8.11B | $8.68B |
| Low | $7.06B | $5.29B | $3.50B | $6.67B | $7.14B |
| High | $9.07B | $7.35B | $8.76B | $9.31B | $9.97B |
| EPS Avg | $4.45 | $3.55 | $3.91 | $4.46 | $4.77 |
| Low | $3.88 | $2.91 | $1.92 | $3.67 | $3.93 |
| High | $4.98 | $4.04 | $4.81 | $5.11 | $5.48 |
| Analysts (Rev / EPS) | 3 / 6 | 3 / 6 | 1 / 7 | 1 / 2 | 1 / 5 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $14.99B | $14.38B | $12.76B | $12.91B | $13.04B | $13.06B | $12.80B | $12.84B |
| Low | $13.91B | $14.03B | $12.45B | $12.60B | $12.72B | $12.74B | $12.49B | $12.53B |
| High | $16.06B | $14.73B | $13.07B | $13.23B | $13.35B | $13.37B | $13.12B | $13.16B |
| EBITDA Avg | $2.69B | $2.58B | $2.29B | $2.32B | $2.34B | $2.34B | $2.30B | $2.31B |
| Low | $2.50B | $2.52B | $2.24B | $2.26B | $2.28B | $2.29B | $2.24B | $2.25B |
| High | $2.88B | $2.65B | $2.35B | $2.37B | $2.40B | $2.40B | $2.36B | $2.36B |
| EBIT Avg | $1.40B | $1.34B | $1.19B | $1.20B | $1.22B | $1.22B | $1.19B | $1.20B |
| Low | $1.30B | $1.31B | $1.16B | $1.18B | $1.19B | $1.19B | $1.17B | $1.17B |
| High | $1.50B | $1.37B | $1.22B | $1.23B | $1.25B | $1.25B | $1.22B | $1.23B |
| Net Income Avg | $2.23B | $1.81B | $1.64B | $1.54B | $1.68B | $1.53B | $1.57B | $1.58B |
| Low | $2.16B | $1.75B | $1.58B | $1.49B | $1.62B | $1.49B | $1.52B | $1.53B |
| High | $2.30B | $1.86B | $1.69B | $1.58B | $1.73B | $1.58B | $1.62B | $1.63B |
| EPS Avg | $1.19 | $0.96 | $0.87 | $0.82 | $0.89 | $0.82 | $0.84 | $0.84 |
| Low | $1.15 | $0.93 | $0.84 | $0.79 | $0.86 | $0.79 | $0.81 | $0.82 |
| High | $1.22 | $0.99 | $0.90 | $0.84 | $0.92 | $0.84 | $0.86 | $0.87 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |